NCT06053333

Brief Summary

This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
27mo left

Started Jul 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Jul 2023Jul 2028

Study Start

First participant enrolled

July 17, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 25, 2023

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2028

Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

5 years

First QC Date

September 18, 2023

Last Update Submit

February 3, 2026

Conditions

Malignant Hepatobiliary Neoplasm

Outcome Measures

Primary Outcomes (1)

  • Percentage of patients reporting transportation barriers that affect medical care

    Estimated using Social Determinants of Health Screening Tool designed by the American Academy of Family Medicine, by the proportion of patients who respond "yes" to the question, "Do you put off or neglect going to the doctor because of distance or transportation?".

    Baseline; up to 2 years

Study Arms (1)

Observational

Patients complete a questionnaire, undergo blood, urine, and buccal swab sample collection and have their medical records reviewed on study. Patients also undergo collection of clinically archived tissue samples on study.

Other: Non-Interventional Study

Interventions

Non-Interventional StudyOTHER

Non-interventional study

Observational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with hepatobiliary cancers

You may qualify if:

  • Patients 18+ year of age with hepatobiliary cancers

You may not qualify if:

  • Patients under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Related Links

Study Officials

  • Nguyen H. Tran, M.D.

    Mayo Clinic in Rochester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clinical Trials Referral Office

CONTACT

855-776-0015mayocliniccancerstudies@mayo.edu

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2023

First Posted

September 25, 2023

Study Start

July 17, 2023

Primary Completion (Estimated)

July 17, 2028

Study Completion (Estimated)

July 17, 2028

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations

US(1)